Immunodeficiency	NN	O
disorders	NNS	O
(	-LRB-	O
representing	VBG	O
an	DT	O
underactive	JJ	O
immune	JJ	O
system	NN	O
)	-RRB-	O
have	VBP	O
been	VBN	O
reported	VBN	O
.	.	O

As	RB	O
early	RB	O
as	IN	O
1989	CD	O
,	,	O
a	DT	O
study	NN	O
was	VBD	O
published	VBN	O
in	IN	O
Australia	NNP	O
that	WDT	O
documented	VBD	O
a	DT	O
loss	NN	O
of	IN	O
immunological	JJ	O
integrity	NN	O
in	IN	O
one	CD	O
hundred	CD	O
CFS	NNP	O
sufferers	NNS	O
.	.	O

The	DT	O
authors	NNS	O
reported	VBD	O
finding	VBG	O
disordered	JJ	O
ratios	NNS	O
of	IN	O
T	NN	O
-	HYPH	O
cell	NN	O
subsets	NNS	O
and	CC	O
reduced	JJ	O
levels	NNS	O
of	IN	O
immunoglobulins	NNS	O
specifically	RB	O
IgG	NNP	O
1	CD	O
and	CC	O
IgG	NNP	O
3	CD	O
;	:	O
these	DT	O
findings	NNS	O
corresponded	VBD	O
with	IN	O
similar	JJ	O
findings	NNS	O
in	IN	O
the	DT	O
U.S.	NNP	O
among	IN	O
leading	VBG	O
researchers	NNS	O
.	.	O

Most	JJS	O
strikingly	RB	O
,	,	O
using	VBG	O
the	DT	O
French	JJ	O
Multitest	NNP	O
to	TO	O
measure	VB	O
the	DT	O
body	NN	O
's	POS	O
response	NN	O
to	IN	O
a	DT	O
variety	NN	O
of	IN	O
antigens	NNS	O
,	,	O
the	DT	O
Australian	JJ	O
group	NN	O
found	VBD	O
that	IN	O
33	CD	O
%	NN	O
of	IN	O
the	DT	O
subjects	NNS	O
were	VBD	O
hypoallergic	JJ	O
,	,	O
meaning	VBG	O
they	PRP	O
had	VBD	O
a	DT	O
reduced	VBN	O
immune	JJ	O
response	NN	O
,	,	O
while	IN	O
an	DT	O
additional	JJ	O
55	CD	O
%	NN	O
were	VBD	O
completely	RB	O
anergic	JJ	O
,	,	O
meaning	VBG	O
they	PRP	O
had	VBD	O
no	DT	O
immune	JJ	O
response	NN	O
at	IN	O
all	RB	O
.	.	O

Some	DT	B
theories	NNS	I
propose	VB	O
that	IN	O
an	DT	O
infection	NN	O
with	IN	O
one	CD	O
of	IN	O
the	DT	O
below	RB	O
-	HYPH	O
listed	VBN	O
disease	NN	O
agents	NNS	O
somehow	RB	O
leads	VBZ	O
to	IN	O
immune	VB	O
dysfunction	NN	O
and	CC	O
chronic	JJ	O
fatigue	NN	O
in	IN	O
cases	NNS	O
of	IN	O
CFS.	NNP	O

This	DT	O
is	VBZ	O
partly	RB	O
supported	VBN	O
by	IN	O
test	NN	O
results	NNS	O
indicating	VBG	O
lowered	VBN	O
or	CC	O
changed	VBN	O
immune	JJ	O
responses	NNS	O
in	IN	O
some	DT	O
patients	NNS	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
elevated	JJ	O
levels	NNS	O
of	IN	O
infectious	JJ	O
agents	NNS	O
in	IN	O
some	DT	O
patients	NNS	O
'	POS	O
blood	NN	O
.	.	O

